Redell, Mark
Article History
First Online: 25 June 2020
Compliance with Ethical Standards
:
: This article was funded by Melinta Therapeutics, Morristown, NJ, USA. This manuscript is part of a supplement wholly funded by Melinta Therapeutics.
: Dr. Mark Redell has received salary and stock options as an employee of Melinta Therapeutics, manufacturer of oritavancin.